In some embodiments, high viscosity formulations or devices contain from about 15% to about 21% of a viscosity enhancing agent or viscosity modulating agent (e.g., gelling components such as polyoxyethylene-polyoxypropylene copolymers)
Self-treatment can lead to addiction to NSAIDs and serious consequences related to changes in the digestive system, kidneys, liver, or respiratory system in people with asthma
Decreasing the dose in most cases can fix this
Expect 30-40% reduction in severity, which often makes the difference between barely functional and tolerably uncomfortable
Therapies such as Epithalon, SS-31, GHK-Cu, and NAD+ focus on improving cellular resilience and long-term physiological function
Some patients might feel uneasy about giving themselves injections or forget when its time